Moreover, the therapeutic effects of paroxetine therapy are associated with polymorphism of the BDNF gene, whereby carriers of the A allele of BDNF G196A polymorphism respond better to the paroxetine therapy in AD-related depression [268]. This evidence concerns the gene BDNF and Alzheimer disease.